Based on these studies and the results of the present study, we hypothesized that the differences in the molecular structures of Smad2 and Smad3 may be the reason underlying why Smad3 has a significant effect on the regulation of TGFβ2-induced cell proliferation in glioma cells. Here, SMAD3 is linked to central nervous system cancer.